Full Text View
Tabular View
No Study Results Posted
Related Studies
Renal Graft Function After Treatment With Erythropoietin (EPO) (FRETEP)
This study has been terminated.
( Lack of patients eligible for the study. )
Study NCT01450878   Information provided by University Hospital, Limoges

First Received on October 10, 2011.   Last Updated on April 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ischemia
More general conditions related to this trial
Pathologic Processes
Interventions listed in this trial
beta-epoietin
Additional drug interventions recognized in this trial
Epoetin Alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University Hospital, Limoges
Hoffmann-La Roche


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services